[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2012163415A1 - Catheter for directing biliopancreatic secretions - Google Patents

Catheter for directing biliopancreatic secretions Download PDF

Info

Publication number
WO2012163415A1
WO2012163415A1 PCT/EP2011/058983 EP2011058983W WO2012163415A1 WO 2012163415 A1 WO2012163415 A1 WO 2012163415A1 EP 2011058983 W EP2011058983 W EP 2011058983W WO 2012163415 A1 WO2012163415 A1 WO 2012163415A1
Authority
WO
WIPO (PCT)
Prior art keywords
catheter
sweeping
tubular wall
grid
sweeping grid
Prior art date
Application number
PCT/EP2011/058983
Other languages
French (fr)
Inventor
Alessandro Pastorelli
Michele D'arcangelo
Original Assignee
Ethicon Endo-Surgery, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Endo-Surgery, Inc. filed Critical Ethicon Endo-Surgery, Inc.
Priority to PCT/EP2011/058983 priority Critical patent/WO2012163415A1/en
Publication of WO2012163415A1 publication Critical patent/WO2012163415A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M27/00Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
    • A61M27/002Implant devices for drainage of body fluids from one part of the body to another
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2002/041Bile ducts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0017Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections

Definitions

  • the present invention relates, in general, to devices and methods for surgically influencing the digestion of a patient with the aim to treat metabolic disorders, such as morbid obesity and related co-morbidities, such as diabetes, heart disease, stroke, pulmonary disease, and accidents.
  • metabolic disorders such as morbid obesity and related co-morbidities, such as diabetes, heart disease, stroke, pulmonary disease, and accidents.
  • a known minimally invasive bypass system and method for modifying the location at which bile and pancreatic secretions interact with nutrients in a gastrointestinal tract has been e.g. discussed in US 2005085787 Al .
  • the known system comprises a conduit having a first end which diverts bile and pancreatic secretions from the ampulla of Vater to a location downstream in the gastrointestinal tract and a second end attached to the ampulla of Vater.
  • Bile catheter obstructions and the subsequent failure of drainage of the biliopancreatic juices would lead to complications, such as jaundice and cholangitis, and must therefore be obviated by exchanging the entire catheter.
  • Clinical catheter occlusion has been observed to occur in 28% - 58% of patients after a time interval of 131 days to 324 days. Even though the mechanism of catheter occlusion is not yet completely understood, it has been postulated that shortly after the implantation of a plastic stent or catheter, proteins contained in the biliary fluid, such as fibronectin, collagen, fibrin and immunoglobulin A, coat the internal catheter surface and promote harboring of bacteria.
  • glycocalix formation by the adhered bacteria forms a gel-like biofilm that protects the bacteria from antibiotics, from the action of the immune system and also from the mechanical shearing effect of the bile flow through the catheter.
  • commonly found microorganisms in the sludge such as Escherichia coli, can produce ⁇ - g 1 u c o r o n i d a s e , which can deconjugate bilirubin glucoronide and precipitate calcium bilirubinate which adds to the depositions inside the catheter.
  • An aim of the present invention is therefore to provide a catheter for directing biliopancreatic secretions, wherein the catheter obviates premature obstruction and assures a sufficient patency for the planned catheter life time.
  • a catheter for directing biliopancreatic secretions comprising an elongate tubular wall extending between a first end portion and a second end portion and having an internal surface which defines a fluid passage channel of the catheter, a sweeping grid arranged inside the fluid passage channel and adapted to be moved with respect to the tubular wall and to sweep said internal surface during said movement, and actuating means for moving the sweeping grid with respect to the tubular wall .
  • the rubbing action of the sweeping grid on the tubular wall tears and removes adhering biological film, bacteria and sediment deposits from the internal surface, thereby significantly improving the patency and increasing the duration of the catheter.
  • FIG. 1 illustrates a catheter for directing biliopancreatic juices implanted in the GI tract of a patient ;
  • FIG. 2 is a cross-sectional view of the catheter in accordance with an embodiment
  • FIG. 3 is a transparent perspective view of a portion of a catheter for directing biliopancreatic juices in accordance with an embodiment
  • Figure 4 is a transparent perspective view of a portion of a catheter for directing biliopancreatic juices in accordance with a further embodiment
  • - Figure 5 is a cross-sectional view of a portion of the catheter for directing biliopancreatic juices in working conditions
  • FIG. 6 is a cross-sectional view of a portion of the catheter for directing biliopancreatic juices, illustrating rotational activating means for moving a sweeping grid;
  • FIG. 7 is a cross-sectional view of a portion of the catheter for directing biliopancreatic juices in accordance with a further embodiment
  • FIG. 8 is a cross-sectional view of a portion of the catheter for directing biliopancreatic juices in accordance with a yet further embodiment
  • FIG. 9 is a cross-sectional view of a portion of the catheter for directing biliopancreatic juices in accordance with a yet further embodiment.
  • figure 1 is a partial view of the abdominal cavity of a patient, depicting the gastrointestinal tract with the esophagus 1, stomach 2, duodenum 3, jejunum 4, ileum 5, colon 6, as well as the hepatic-biliary system with the liver, the biliary tree 7 with gall bladder 8, the pancreatic duct 9 and the mayor duodenal papilla of Vater 10 through which the bile and pancreatic fluid normally enter the duodenum 3.
  • Figure 1 shows further a catheter 11 for modifying the location at which biliopancreatic secretions interact with nutrients and with the intestinal wall in a gastrointestinal tract.
  • the catheter 11 comprises a proximal end portion 12 adapted to be fluid connected to the common bile duct 7 to collect biliopancreatic secretions and a distal end portion 13 adapted to be placed in a location downstream in the gastrointestinal tract, that is to say in a location significantly distal to the papilla of Vater, such as in the distal section of the duodenum 3, in the jejunum 4 or ileum 5.
  • the catheter proximal end portion 12 may have only one proximal open end 14 which can be arranged and anchored (e.g.
  • the proximal end portion 12 may be bifurcated or Y- shaped and define a proximal open bile end 14 intended and adapted to be inserted in the bile duct 7 proximal to the junction point with the pancreatic duct 9, and a proximal open pancreatic end 14' intended and adapted to be inserted in the pancreatic duct 7.
  • a Y-shaped proximal end portion 12 would allow to collect bile and pancreatic juices separately and to keep them isolated or mix them further distally in the catheter 11.
  • the catheter distal end portion 13 forms one or more bile outlet openings 15 through which the biliopancreatic juices are released into the intestine.
  • the catheter 11 comprises an elongate tubular wall 16 extending between the proximal end portion 12 and the distal end portion 13 and having an internal surface 17 which defines a fluid passage channel 18 of the catheter 11.
  • a sweeping grid 19 is arranged inside the fluid passage channel 18 and adapted to be moved with respect to the tubular wall 16 and to sweep the internal surface 17 during the movement of grid 19.
  • the catheter 11 comprises further actuating means 20 for moving the sweeping grid 19 with respect to the tubular wall 16.
  • the sweeping grid 19 has a generally tubular shape and is arranged immediately adjacent to and concentric with the tubular wall 16.
  • the tubular sweeping grid 9 forms a plurality of interconnected scraping bars 21 and a plurality of window openings 22 between the scraping bars 21, wherein the window openings 22 expose portions of the internal surface 17 of the tubular wall 16 to the fluid passage channel 18 and, during the movement of the sweeping grid 19, the scraping bars 21 sweep over the exposed internal surface 17 portions and detach undesired depositions of biofilm and sediments which could otherwise lead to catheter clogging.
  • the area of the internal surface 17 covered by all scraping bars 21 of the grid 19 is smaller, preferably significantly smaller, than the area of the internal surface 17 exposed through the window openings 22 of the grid 19. In this manner a predominant area of the entire catheter surface (i.e. of the outer wall and of the grid) defining the fluid passage channel 18 is swept and cleaned from undesired sludge depositions and only a minor surface area (i.e. the surface of the scraping bars 21 of the sweeping grid 19) is not subjected to direct cleansing action.
  • the comparatively thin shape and small dimensions of the scraping bars 21 of the sweeping grid 19 provide only a very poor harboring surface for undesired depositions, which can accumulate only to a non-critical size above which they tend to break and detach due to an insufficient anchoring area.
  • the area of all window openings 22 of the sweeping grid 19 is greater than the area of the scraping bars 21 thereof, or in other words of the structure of the sweeping grid 19 (the generally tubular curved grid 19 is considered to be developed in a plane and the areas are measured in this development plane) , preferably the ratio of the area of all window openings 22 of the sweeping grid 19 divided by the area of the scraping bars 21 or, in other words, of the structure of the sweeping grid 19 is greater than 2, even more preferably greater than 3.
  • the sweeping grid 19 extends or moves along a predominant part of the length of the catheter 11 or along the entire length of the catheter, including the proximal end portion 12 and the distal end portion 13 thereof in order to clean also the proximal and distal open ends 14, 15.
  • the tubular wall 16 is continuous and without lateral apertures in the regions overlapped by the window openings 22 of the sweeping grid.
  • the sweeping grid 19 may be formed by a plastic tube provided with cut out apertures forming the window openings 22 or, alternatively, the sweeping grid 19 may be formed by a tubular mesh of metal wire or plastic wire 23, in which the wire 23 forms the above said scraping bars 21.
  • the scraping bars 21 of the sweeping grid 19 may comprise a scraping surface 24 forming an obtuse angle ⁇ with the internal surface 17 exposed through the adjacent window opening 22 and converging in a sharp scraping edge 24 adapted to cut through and scrape away depositions from the internal surface 17 during the t r a n s 1 a t i o n a 1 or rotational movement of the sweeping grid 19 with respect to the tubular wall 16.
  • the actuating means 20 are configured to move the sweeping grid 19 intermittently or continuously with respect to the tubular wall 16, wherein the movement may be an alternating translational back and forth movement in a longitudinal direction of the catheter 11 or a rotational movement about a longitudinal catheter axis.
  • the rotational movement may comprise a cyclic unidirectional rotation and/or a back and forth type alternating rotation.
  • the actuating means 20 may comprise an electric motor formed by stator windings 25 connected to (preferably incorporated or encapsulated in) the tubular wall 16 and rotor magnets 26 or windings connected to (preferably incorporated or encapsulated in) the sweeping grid 19.
  • the actuating means 20 may comprise one or more linear micromotors 27, such as a piezoelectric motor, connected to the tubular wall 16 and engaging with and adapted to travel along a longitudinal or circumferential guide rail 28 formed on the sweeping grid 19 to move (translate or rotate) the latter with respect to the tubular wall 16.
  • Such a piezoelectric motor may have a reciprocating expanding lateral piezo member pushing on two clutching piezo members mounted inside a tubular housing and electrified in sequence to grip the guide rail which is then moved.
  • An exemplary, non limiting example of such a piezoelectric motor is the P-652-series PILine® ultrasonic motor linear slides.
  • the activation means 20 may be locally controlled by an onboard controller or remote controlled, e.g. by means of wireless RF signal communication between an extracorporeal control unit and a local controller associated with the actuating means.
  • the actuation means may further comprise a battery having a charging level sufficient for the planned life time of the catheter 11 or a remotely rechargeable battery, e.g. by means of an inductive extracorporeal charger.
  • the actuations means are configured to automatically move the sweeping grid 19 with respect to the tubular wall 16, e.g. following an intermittent actuation scheme which performs e.g. every 24 hours a short movement period of e.g. 15 seconds - 120 seconds.
  • the tubular wall 16 and also the sweeping grid 19 are preferably flexible to facilitate the implantation of the catheter and to better follow the physiological structures to which the catheter 11 is applied.
  • the tubular wall 16 may be grafted at least partially in silicone, polyethylene, polypropylene, butylated rubber, latex and the like.
  • the tubular wall 16 may be additionally reinforced with a metal or plastic wire mesh 29, e.g. with a braided wire mesh, which can be coextruded together with or incorporated and encapsulated in the tubular wall 16 base material (e.g. polyethylene) .
  • a metal or plastic wire mesh 29 e.g. with a braided wire mesh, which can be coextruded together with or incorporated and encapsulated in the tubular wall 16 base material (e.g. polyethylene) .
  • the catheter 11 can be installed endoluminally, e.g. transorally, in the intestine and the proximal end portion 12 of the catheter 11 may be inserted in the papilla of Vater 10 using e.g. an ERCP (Endoscopic Retrograde Cholangio Pancreatography) like technique.
  • the ERCP procedure involves passing a flexible endoscope through the mouth, esophagus 1, and stomach 2 into the duodenum 3 near the papilla of Vater 10. The doctor then passes the catheter 11 through a channel in the endoscope and out into view in the duodenum 3 and inserts it into the papilla of Vater 10.
  • the present invention further contemplates the possibility of placing the catheter 11 in the intestine and introducing the catheter proximal end portion 12 in the papilla of Vater 10 by laparoscopically accessing the abdominal space, t r an s 1 umen a 11 y accessing the duodenum 3 near the papilla of Vater 10 and placing the catheter 11 through the duodenum 3 in the desired position within the intestine and, from inside the duodenum 3, laparoscopically introducing the catheter proximal end portion 12 into the papilla of Vater 10.
  • the catheter 11 and methods of the described invention assure an improved patency over time and reduce the risk of catheter clogging and related clinical complications.
  • the described catheter obviates the need of frequent catheter replacements and, hence, the need of frequent surgical manipulation of the region of the biliary tree and pancreatic duct

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

A catheter (11) for directing biliopancreatic secretions comprises an elongate tubular wall (16) extending between a proximal end portion (12) and a distal end portion (13) and having an internal surface (17) which defines a fluid passage channel (18), a sweeping grid (19) arranged inside the fluid passage channel (18) and adapted to be moved with respect to the tubular wall (16) thereby sweeping the internal surface (17), actuating means (20) which move the sweeping grid (19) with respect to the tubular wall (16).

Description

DESCRIPTION
CATHETER FOR DIRECTING BILIOPANCREATIC SECRETIONS
The present invention relates, in general, to devices and methods for surgically influencing the digestion of a patient with the aim to treat metabolic disorders, such as morbid obesity and related co-morbidities, such as diabetes, heart disease, stroke, pulmonary disease, and accidents.
Numerous non-operative therapies for morbid obesity have been tried in the past with virtually no permanent success .
Surgical methods of treating morbid obesity, such as open, laparoscopic and endoluminal gastric bypass surgery aiming to permanent malabsorption of the food, have been increasingly used with greater success. However, current methods for performing a gastric bypass involve time-consuming and highly dexterity dependent surgical techniques as well as significant and generally highly invasive modifications of the patients gastrointestinal anatomy. These procedures are reserved only for the severely obese patients because they have a number of significant complications, including the risk of death. In order to avoid the drawbacks of gastric bypass surgery and to influence the digestion of a patient in a more specific and aimed way, the present invention focuses on methods and devices for primarily influencing and modifying the entero-hepatic bile cycling rather than the digestive tract itself. To this end, the following possible approaches and mechanisms of action on the entero-hepatic bile cycling are contemplated :
modification of the entero-hepatic bile cycling frequency, particularly bile cycle acceleration;
- modification of the physiological signaling triggered by the contact and interaction of the bile with the food in the intestine and by the contact of the bile with the intestinal wall;
- modification of the food absorbability by modifying the contact space and time between the bile and the food or chime in the intestine as well as by an aimed separation of the bile from the food.
A known minimally invasive bypass system and method for modifying the location at which bile and pancreatic secretions interact with nutrients in a gastrointestinal tract has been e.g. discussed in US 2005085787 Al . The known system comprises a conduit having a first end which diverts bile and pancreatic secretions from the ampulla of Vater to a location downstream in the gastrointestinal tract and a second end attached to the ampulla of Vater.
One of the major problems with plastic catheters is their tendency to clog over time. Bile catheter obstructions and the subsequent failure of drainage of the biliopancreatic juices would lead to complications, such as jaundice and cholangitis, and must therefore be obviated by exchanging the entire catheter. Clinical catheter occlusion has been observed to occur in 28% - 58% of patients after a time interval of 131 days to 324 days. Even though the mechanism of catheter occlusion is not yet completely understood, it has been postulated that shortly after the implantation of a plastic stent or catheter, proteins contained in the biliary fluid, such as fibronectin, collagen, fibrin and immunoglobulin A, coat the internal catheter surface and promote harboring of bacteria. Subsequent glycocalix formation by the adhered bacteria forms a gel-like biofilm that protects the bacteria from antibiotics, from the action of the immune system and also from the mechanical shearing effect of the bile flow through the catheter. In addition, commonly found microorganisms in the sludge, such as Escherichia coli, can produce β- g 1 u c o r o n i d a s e , which can deconjugate bilirubin glucoronide and precipitate calcium bilirubinate which adds to the depositions inside the catheter. Research over the past two decades has concentrated on improving the patency of implanted catheters and stents focusing on appropriate materials, catheter- and stent position, catheter shape and dimensions, as well as on the administration of antibiotics and drugs affecting the constituents of the biliary fluid and the depositions and sediments inside the catheter. However, to date, catheter diameter dimensioning is the only factor that has proven to effectively influence catheter patency and clogging time.
An aim of the present invention is therefore to provide a catheter for directing biliopancreatic secretions, wherein the catheter obviates premature obstruction and assures a sufficient patency for the planned catheter life time.
This and other aims are achieved by a catheter for directing biliopancreatic secretions, the catheter comprising an elongate tubular wall extending between a first end portion and a second end portion and having an internal surface which defines a fluid passage channel of the catheter, a sweeping grid arranged inside the fluid passage channel and adapted to be moved with respect to the tubular wall and to sweep said internal surface during said movement, and actuating means for moving the sweeping grid with respect to the tubular wall .
The rubbing action of the sweeping grid on the tubular wall tears and removes adhering biological film, bacteria and sediment deposits from the internal surface, thereby significantly improving the patency and increasing the duration of the catheter.
These and other aspects and advantages of the present invention shall be made apparent from the accompanying drawings and the description thereof, which illustrate embodiments of the invention and, together with the general description of the invention given above, and the detailed description of the embodiments given below, serve to explain the principles of the present invention .
- Figure 1 illustrates a catheter for directing biliopancreatic juices implanted in the GI tract of a patient ;
- Figure 2 is a cross-sectional view of the catheter in accordance with an embodiment;
- Figure 3 is a transparent perspective view of a portion of a catheter for directing biliopancreatic juices in accordance with an embodiment;
Figure 4 is a transparent perspective view of a portion of a catheter for directing biliopancreatic juices in accordance with a further embodiment; - Figure 5 is a cross-sectional view of a portion of the catheter for directing biliopancreatic juices in working conditions;
- Figure 6 is a cross-sectional view of a portion of the catheter for directing biliopancreatic juices, illustrating rotational activating means for moving a sweeping grid;
- Figure 7 is a cross-sectional view of a portion of the catheter for directing biliopancreatic juices in accordance with a further embodiment;
- Figure 8 is a cross-sectional view of a portion of the catheter for directing biliopancreatic juices in accordance with a yet further embodiment;
- Figure 9 is a cross-sectional view of a portion of the catheter for directing biliopancreatic juices in accordance with a yet further embodiment.
Referring to the drawings in which like numerals denote like anatomical structures and components throughout the several views, figure 1 is a partial view of the abdominal cavity of a patient, depicting the gastrointestinal tract with the esophagus 1, stomach 2, duodenum 3, jejunum 4, ileum 5, colon 6, as well as the hepatic-biliary system with the liver, the biliary tree 7 with gall bladder 8, the pancreatic duct 9 and the mayor duodenal papilla of Vater 10 through which the bile and pancreatic fluid normally enter the duodenum 3. Figure 1 shows further a catheter 11 for modifying the location at which biliopancreatic secretions interact with nutrients and with the intestinal wall in a gastrointestinal tract.
The catheter 11 comprises a proximal end portion 12 adapted to be fluid connected to the common bile duct 7 to collect biliopancreatic secretions and a distal end portion 13 adapted to be placed in a location downstream in the gastrointestinal tract, that is to say in a location significantly distal to the papilla of Vater, such as in the distal section of the duodenum 3, in the jejunum 4 or ileum 5. The catheter proximal end portion 12 may have only one proximal open end 14 which can be arranged and anchored (e.g. by means of a stent) in the bile duct proximally (to collect only bile) or distally to the junction point with the pancreatic duct 9 (to collect both bile and pancreatic juices). Alternatively, the proximal end portion 12 may be bifurcated or Y- shaped and define a proximal open bile end 14 intended and adapted to be inserted in the bile duct 7 proximal to the junction point with the pancreatic duct 9, and a proximal open pancreatic end 14' intended and adapted to be inserted in the pancreatic duct 7. Such a Y-shaped proximal end portion 12 would allow to collect bile and pancreatic juices separately and to keep them isolated or mix them further distally in the catheter 11.
The catheter distal end portion 13 forms one or more bile outlet openings 15 through which the biliopancreatic juices are released into the intestine. In accordance with an aspect of the invention, the catheter 11 comprises an elongate tubular wall 16 extending between the proximal end portion 12 and the distal end portion 13 and having an internal surface 17 which defines a fluid passage channel 18 of the catheter 11. A sweeping grid 19 is arranged inside the fluid passage channel 18 and adapted to be moved with respect to the tubular wall 16 and to sweep the internal surface 17 during the movement of grid 19.
The catheter 11 comprises further actuating means 20 for moving the sweeping grid 19 with respect to the tubular wall 16.
The rubbing action of the sweeping grid 19 on the tubular wall 16 tears and removes adhering biological film, bacteria and sediment deposits from the internal surface 17. This leads to significant improvements of the patency of the catheter and, hence, to an increase of the catheter duration.
In accordance with an embodiment, the sweeping grid 19 has a generally tubular shape and is arranged immediately adjacent to and concentric with the tubular wall 16. The tubular sweeping grid 9 forms a plurality of interconnected scraping bars 21 and a plurality of window openings 22 between the scraping bars 21, wherein the window openings 22 expose portions of the internal surface 17 of the tubular wall 16 to the fluid passage channel 18 and, during the movement of the sweeping grid 19, the scraping bars 21 sweep over the exposed internal surface 17 portions and detach undesired depositions of biofilm and sediments which could otherwise lead to catheter clogging.
In accordance with an embodiment, the area of the internal surface 17 covered by all scraping bars 21 of the grid 19 is smaller, preferably significantly smaller, than the area of the internal surface 17 exposed through the window openings 22 of the grid 19. In this manner a predominant area of the entire catheter surface (i.e. of the outer wall and of the grid) defining the fluid passage channel 18 is swept and cleaned from undesired sludge depositions and only a minor surface area (i.e. the surface of the scraping bars 21 of the sweeping grid 19) is not subjected to direct cleansing action.
Moreover, the comparatively thin shape and small dimensions of the scraping bars 21 of the sweeping grid 19 provide only a very poor harboring surface for undesired depositions, which can accumulate only to a non-critical size above which they tend to break and detach due to an insufficient anchoring area.
In accordance with an embodiment, the area of all window openings 22 of the sweeping grid 19 is greater than the area of the scraping bars 21 thereof, or in other words of the structure of the sweeping grid 19 (the generally tubular curved grid 19 is considered to be developed in a plane and the areas are measured in this development plane) , preferably the ratio of the area of all window openings 22 of the sweeping grid 19 divided by the area of the scraping bars 21 or, in other words, of the structure of the sweeping grid 19 is greater than 2, even more preferably greater than 3.
In accordance with an embodiment, the sweeping grid 19 extends or moves along a predominant part of the length of the catheter 11 or along the entire length of the catheter, including the proximal end portion 12 and the distal end portion 13 thereof in order to clean also the proximal and distal open ends 14, 15.
Preferably, the tubular wall 16 is continuous and without lateral apertures in the regions overlapped by the window openings 22 of the sweeping grid.
The sweeping grid 19 may be formed by a plastic tube provided with cut out apertures forming the window openings 22 or, alternatively, the sweeping grid 19 may be formed by a tubular mesh of metal wire or plastic wire 23, in which the wire 23 forms the above said scraping bars 21.
In accordance with a further embodiment, the scraping bars 21 of the sweeping grid 19 may comprise a scraping surface 24 forming an obtuse angle β with the internal surface 17 exposed through the adjacent window opening 22 and converging in a sharp scraping edge 24 adapted to cut through and scrape away depositions from the internal surface 17 during the t r a n s 1 a t i o n a 1 or rotational movement of the sweeping grid 19 with respect to the tubular wall 16.
In accordance with an embodiment, the actuating means 20 are configured to move the sweeping grid 19 intermittently or continuously with respect to the tubular wall 16, wherein the movement may be an alternating translational back and forth movement in a longitudinal direction of the catheter 11 or a rotational movement about a longitudinal catheter axis. The rotational movement may comprise a cyclic unidirectional rotation and/or a back and forth type alternating rotation.
In accordance with a non-limiting exemplary embodiment, the actuating means 20 may comprise an electric motor formed by stator windings 25 connected to (preferably incorporated or encapsulated in) the tubular wall 16 and rotor magnets 26 or windings connected to (preferably incorporated or encapsulated in) the sweeping grid 19. Alternati ely, the actuating means 20 may comprise one or more linear micromotors 27, such as a piezoelectric motor, connected to the tubular wall 16 and engaging with and adapted to travel along a longitudinal or circumferential guide rail 28 formed on the sweeping grid 19 to move (translate or rotate) the latter with respect to the tubular wall 16.
Such a piezoelectric motor may have a reciprocating expanding lateral piezo member pushing on two clutching piezo members mounted inside a tubular housing and electrified in sequence to grip the guide rail which is then moved. An exemplary, non limiting example of such a piezoelectric motor is the P-652-series PILine® ultrasonic motor linear slides.
In accordance with a further embodiment, the activation means 20 may be locally controlled by an onboard controller or remote controlled, e.g. by means of wireless RF signal communication between an extracorporeal control unit and a local controller associated with the actuating means. The actuation means may further comprise a battery having a charging level sufficient for the planned life time of the catheter 11 or a remotely rechargeable battery, e.g. by means of an inductive extracorporeal charger.
The actuations means are configured to automatically move the sweeping grid 19 with respect to the tubular wall 16, e.g. following an intermittent actuation scheme which performs e.g. every 24 hours a short movement period of e.g. 15 seconds - 120 seconds.
The tubular wall 16 and also the sweeping grid 19 are preferably flexible to facilitate the implantation of the catheter and to better follow the physiological structures to which the catheter 11 is applied. The tubular wall 16 may be grafted at least partially in silicone, polyethylene, polypropylene, butylated rubber, latex and the like.
In order to increase torque-, kink- and compression resistance of the catheter 11, the tubular wall 16 may be additionally reinforced with a metal or plastic wire mesh 29, e.g. with a braided wire mesh, which can be coextruded together with or incorporated and encapsulated in the tubular wall 16 base material (e.g. polyethylene) .
The catheter 11 can be installed endoluminally, e.g. transorally, in the intestine and the proximal end portion 12 of the catheter 11 may be inserted in the papilla of Vater 10 using e.g. an ERCP (Endoscopic Retrograde Cholangio Pancreatography) like technique. The ERCP procedure involves passing a flexible endoscope through the mouth, esophagus 1, and stomach 2 into the duodenum 3 near the papilla of Vater 10. The doctor then passes the catheter 11 through a channel in the endoscope and out into view in the duodenum 3 and inserts it into the papilla of Vater 10.
The present invention further contemplates the possibility of placing the catheter 11 in the intestine and introducing the catheter proximal end portion 12 in the papilla of Vater 10 by laparoscopically accessing the abdominal space, t r an s 1 umen a 11 y accessing the duodenum 3 near the papilla of Vater 10 and placing the catheter 11 through the duodenum 3 in the desired position within the intestine and, from inside the duodenum 3, laparoscopically introducing the catheter proximal end portion 12 into the papilla of Vater 10. The catheter 11 and methods of the described invention assure an improved patency over time and reduce the risk of catheter clogging and related clinical complications. Moreover, the described catheter obviates the need of frequent catheter replacements and, hence, the need of frequent surgical manipulation of the region of the biliary tree and pancreatic duct
Although preferred embodiments of the invention have been described in detail, it is not the intention of the applicant to limit the scope of the claims to such particular embodiments, but to cover all modifications and alternative constructions falling within the scope of the invention.

Claims

1. A catheter (11) for directing biliopancreatic secretions, the catheter (11) comprising:
an elongate tubular wall (16) extending between a proximal end portion (12) and a distal end portion (13) and having an internal surface (17) which defines a fluid passage channel (18),
- a sweeping grid (19) arranged inside the fluid passage channel (18) and adapted to be moved with respect to the tubular wall (16) thereby sweeping the internal surface (17) ,
- actuating means (20) which move the sweeping grid (19) with respect to the tubular wall (16) .
2. A catheter (11) according to claim 1, in which the sweeping grid (19) has a generally tubular shape and is arranged immediately adjacent to and concentric with the tubular wall (16) .
3. A catheter (11) according to claim 1 or 2, in which sweeping grid (9) forms a plurality of interconnected scraping bars (21) and a plurality of window openings (22) between the scraping bars (21), wherein the window openings (22) expose portions of the internal surface (17) to the fluid passage channel (18) and, during the movement of the sweeping grid (19), the scraping bars (21) sweep over the exposed internal surface (17) portions to detach undesired depositions.
4. A catheter (11) according to claim 3, in which the area of the internal surface (17) covered by all scraping bars (21) is smaller than the area of the internal surface (17) exposed through the window openings (22 ) .
5. A catheter (11) according to claim 3, in which the ratio of the area of all window openings (22) divided by the area of the structure of the sweeping grid (19) is greater than 2, preferably greater than 3.
6. A catheter (11) according to any one of the preceding claims, in which sweeping grid (19) is adapted to sweep over a predominant part of the length of the tubular wall (16) .
7. A catheter (11) according to any one of the preceding claims, in which sweeping grid (19) is adapted to sweep over the entire length of the tubular wall (16), including the proximal end portion (12) and the distal end portion (13) thereof.
8. A catheter (11) according to any one of the preceding claims, in which the tubular wall (16) is continuous and without lateral apertures in the regions overlapped by the window openings (22) of the sweeping grid (19) .
9. A catheter (11) according to any one of the preceding claims, in which the sweeping grid (19) is formed by a plastic tube provided with cut out apertures forming the window openings (22) .
10. A catheter (11) according to any one of the preceding claims, in which the sweeping grid (19) is formed by a tubular mesh of wire (23) forming scraping bars (21) .
11. A catheter (11) according to claim 3, in which the scraping bars (21) form a scraping surface (24) which forms an obtuse angle (β) with the internal surface (17) exposed through the adjacent window opening (22) and converges in a sharp scraping edge (24) .
12. A catheter (11) according to claim 1, in which the actuating means (20) are configured to move the sweeping grid (19) intermittently.
13. A catheter (11) according to claim 1, in which the actuating means (20) are configured to move the sweeping grid (19) continuously.
14. A catheter (11) according to claim 1, in which the actuating means (20) comprise an electric motor formed by stator windings (25) connected to the tubular wall (16) and rotor magnets (26) or windings connected to the sweeping grid (19) .
15. A catheter (11) according to claim 1, in which the actuating means (20) comprise a linear micromotor (27), connected to the tubular wall (16) and adapted to engage and travel along a guide rail (28) formed on the sweeping grid (19) to move the sweeping grid (19) with respect to the tubular wall (16) .
16. A method for improving the patency of a catheter (11) for directing bili opancreat ic secretions, the catheter (11) comprising an elongate tubular wall (16) extending between a proximal end portion (12) and a distal end portion (13), the tubular wall (16) having an outer layer ( 17 ) ,
the method comprising the steps of:
- providing at least one sweeping grid (19) inside the fluid passage channel (18), and
- moving said sweeping grid (19) with respect to the tubular wall (16) thereby sweeping the internal surface (17) .
PCT/EP2011/058983 2011-05-31 2011-05-31 Catheter for directing biliopancreatic secretions WO2012163415A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/058983 WO2012163415A1 (en) 2011-05-31 2011-05-31 Catheter for directing biliopancreatic secretions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/058983 WO2012163415A1 (en) 2011-05-31 2011-05-31 Catheter for directing biliopancreatic secretions

Publications (1)

Publication Number Publication Date
WO2012163415A1 true WO2012163415A1 (en) 2012-12-06

Family

ID=44626879

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/058983 WO2012163415A1 (en) 2011-05-31 2011-05-31 Catheter for directing biliopancreatic secretions

Country Status (1)

Country Link
WO (1) WO2012163415A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10449075B2 (en) 2015-12-15 2019-10-22 Steven Sounyoung Yu Biliary diversion catheter

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050085787A1 (en) 2003-10-17 2005-04-21 Laufer Michael D. Minimally invasive gastrointestinal bypass
WO2005067647A2 (en) * 2004-01-09 2005-07-28 The Catheter Exchange, Inc. Drain with occlusion removing structure
WO2008048823A2 (en) * 2006-10-17 2008-04-24 Wilson-Cook Medical Inc. Endoscope-cleaning device
US20090188531A1 (en) * 2008-01-25 2009-07-30 Boyle Jr Edward M Methods and devices to clear obstructions from medical tubes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050085787A1 (en) 2003-10-17 2005-04-21 Laufer Michael D. Minimally invasive gastrointestinal bypass
WO2005067647A2 (en) * 2004-01-09 2005-07-28 The Catheter Exchange, Inc. Drain with occlusion removing structure
WO2008048823A2 (en) * 2006-10-17 2008-04-24 Wilson-Cook Medical Inc. Endoscope-cleaning device
US20090188531A1 (en) * 2008-01-25 2009-07-30 Boyle Jr Edward M Methods and devices to clear obstructions from medical tubes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10449075B2 (en) 2015-12-15 2019-10-22 Steven Sounyoung Yu Biliary diversion catheter

Similar Documents

Publication Publication Date Title
US11642132B2 (en) Incisionless gastric bypass system
US8636751B2 (en) Methods and devices for the rerouting of chyme to induce intestinal brake
US8617095B2 (en) Pancreatic exocrine secretion diversion apparatus and method
US8801647B2 (en) Use of a gastrointestinal sleeve to treat bariatric surgery fistulas and leaks
WO2012163413A1 (en) Catheter for directing biliopancreatic secretions
BRPI1014701B1 (en) modular system to treat metabolic disorders such as diabetes and obesity
US8790322B2 (en) Stoma coat
EP2561840B1 (en) Device for anchoring an endoluminal sleeve in the GI tract
WO2011149879A2 (en) Intestinal brake inducing intraluminal therapeutic substance eluting devices and methods
WO2012007045A1 (en) A device and method for subcutaneous diversion of bile
WO2012163415A1 (en) Catheter for directing biliopancreatic secretions
WO2012007048A1 (en) An apparatus and method for diverting biliopancreatic juices discharged into a patient's intestinal tract
WO2012163412A1 (en) Catheter for directing biliopancreatic secretions
WO2013004262A1 (en) A catheter, particularly for directing biliopancreatic secretions
WO2012007053A1 (en) A length adjustable catheter for directing biliopancreatic secretions
WO2013004269A1 (en) A device and method for conveying bile towards a target location in the intestine
AU2015215834B2 (en) Incisionless gastric bypass method and devices
WO2013004267A1 (en) A catheter, particularly for directing biliopancreatic secretions
WO2012007051A1 (en) A bile draining catheter and method for diverting bile from the gallbladder in the intestine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11724402

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11724402

Country of ref document: EP

Kind code of ref document: A1